Medwatch Alert: FDA Investigating Serious Risk Of Malignancy Linked To Zolgensma Gene Therapy
- Reason
- FDA Investigating Serious Risk of Malignancy Linked to Zolgensma Gene Therapy: FDA Safety Communication
- Category
- drug recall
- Country
- United States
- Agency
- FDA-MEDWATCH-RSS
- Recall date
- 2026-11-06
- Status
- Ongoing
Official recall notice from FDA-MEDWATCH-RSS
Recall details on Nibble Recalls: https://trynibble.app/recalls/5d9fddc2-59eb-419e-bdc0-b4616a7a8352